Autopsy report · NCT01848548

Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study

“Unable to continue recruit subjects”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 4 years 3 months before it stopped.
• 25 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Awake Endotracheal Intubation; Difficult Intubation; Airway Anesthesia

Interventions

Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark

Participants

25

Sites

1

Countries

United States

Trials that died the same way

• Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
  “Unable to recruit any subjects” (85% match in meaning)
• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
  “Not able to recruit subjects” (84% match in meaning)
• Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
  “Unable to recruit a sufficient number of subjects.” (78% match in meaning)
• TubeClear® Evaluation in Pediatric Patients (Phase I)
  “Unable to recruit; study determined not feasible to continue” (78% match in meaning)
• Recombinant Human Prolactin for Lactation Induction
  “Not able to recruit any subjects.” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.